SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001387131-18-003118
Filing Date
2018-07-13
Accepted
2018-07-13 11:33:16
Documents
1
Group Members
ALTIUM CAPITAL GROWTH GP, LLCALTIUM GROWTH FUND, LP

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP ormp-sc13g_071318.htm SC 13G 131269
  Complete submission text file 0001387131-18-003118.txt   133018
Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164
ORAMED PHARMACEUTICALS INC. (Subject) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: SC 13G | Act: 34 | File No.: 005-79895 | Film No.: 18951920
SIC: 2834 Pharmaceutical Preparations

Mailing Address 551 FIFTH AVE - FL 19 NEW YORK NY 10176
Business Address 551 FIFTH AVE - FL 19 NEW YORK NY 10176 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

IRS No.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G